• OPEN AN ACCOUNT
Indian Indices
Sensex
77,264.51 330.92
( 0.43%)
Global Indices
Nasdaq
53,569.16 -21.28
(-0.04%)
Dow Jones
7,731.77 -20.22
(-0.26%)
Hang Seng
66,369.62 237.64
(0.36%)
Nikkei 225
10,816.31 23.77
(0.22%)
Forex
USD-INR
95.48 0.22
(0.23%)
EUR-INR
111.24 0.16
(0.15%)
GBP-INR
129.74 0.04
(0.03%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Va Tech Wabag Ltd
Industry :  Engineering - Turnkey Services
BSE Code
ISIN Demat
Book Value()
533269
INE956G01038
337.4131799
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
WABAG
36.51
13009.2
EPS(TTM)
Face Value()
Div & Yield %
57.03
2
0.24
 

RPG Life Sciences consolidated net profit declines 74.52% in the March 2026 quarter
Apr 30,2026
Net profit of RPG Life Sciences declined 74.52% to Rs 29.90 crore in the quarter ended March 2026 as against Rs 117.35 crore during the previous quarter ended March 2025. Sales rose 23.62% to Rs 176.89 crore in the quarter ended March 2026 as against Rs 143.09 crore during the previous quarter ended March 2025.

For the full year,net profit declined 37.15% to Rs 115.17 crore in the year ended March 2026 as against Rs 183.24 crore during the previous year ended March 2025. Sales rose 8.28% to Rs 707.52 crore in the year ended March 2026 as against Rs 653.43 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales176.89143.09 24 707.52653.43 8
OPM %18.5617.81 -20.7924.43 -
PBDT44.8430.37 48 171.78171.71 0
PBT39.1025.00 56 150.30150.28 0
NP29.90117.35 -75 115.17183.24 -37